Green fluorescent protein (GFP) is a bioluminescent molecule derived from the jellyfish Aequorum victoria (5) . The use of GFP as a recombinant molecule has furthered the study of protein expression, inter-and intracellular trafficking patterns, and the use of flow cytometric analyses. For bacteriologic studies, GFP can be a valuable tool for studying host-pathogen interactions (6) and bacteria-bacteria interactions.
Our goal was to develop a system for expressing GFP in Salmonella, a foodborne pathogen that causes disease throughout the world (4). We were especially interested in using GFP as a marker in Salmonella tvphimurium phagetype DT104 (DT104), a specific Salmonella subtype that exhibits multiple antibiotic resistance and has the potential to behave as a "superpathogen" (7). The GFP-based system could be used to study DTI04 pathogenesis in vitro and ex vivo. To avoid the potential for disrupting any of the metabolic, virulence, or antibiotic resistance genes present in the chromosome of DT104, a plasmidbased system was sought. However, the antibiotic resistance profile of certain DT104 isolates is extensive (ampicillin, chlorarnphenicol, streptomycin, sulfamethoxazole, tetracycline, erythromycin, kanamycin, neomycin, gentamicin, apramycin, etc.); thus, most conventional antibiotic selection-based plasmids are of little value. Consequently, a novel selection system was sought.
Recently, Invitrogen (Carlsbad, CA, USA) unveiled several plasmids carrying a small gene that encodes for resistance to ZeociniM , which is a phleomycin derivative. Since Zeocin resistance (resistance breakpoint of 25 ig/mL) was not observed in our pool of DT 104 isolates (it 425), we felt that a Zeocin resistance plasmid may be a useful tool for expressing GFP in multiresistant Salmonella.
Our initial approach was to determine an appropriate GFP or GFP-like protein for expression in Salmonella. This initial screening process was performed by transforming GFP vectors (Living Colors®, pEGFP, pECFP, pEYFP; ampicillin resistance; Clontech Laboratories, Palo Alto, CA, USA) into electrocompetent S. tvphimuriuni LB-5000, a restriction negative/modification positive strain of Salmonella (1). Electrocompetent bacteria were derived by washing and resuspending bacterial pellets three times in water. Bacterial pellets were finally dissolved in 40% glycerol. Electroporation utilized approximately 1010 bacteria and 0.1 tg plasmid DNA in 0.2-cm cuvettes (BioRad Laboratories, Hercules, CA, USA). Electroporation was performed at 2.5 kV and 25 lIE. Transformed S. typhimurium LB 5000 were plated on Lennox L (Life Technologies, Rockville, MD, USA) agar plates containing 100 g/mL ampicillin. Based on a comparison to fluorescence in E. coli HB10I transformed with a GFP or GFP-like vector, we found that expression of ECFP was most conducive for standard UV light visualization in Salmonella. ECFP is a cyan emission mutant of GFP with excitation and emission spectra of 433 and 475 nm, respectively (2).
To express ECFP in a Zeocin-contaming vector, we chose to clone the ECFP gene (from pECFP) into pCRBlunt 11-TOPO ® (Invitrogen). This vector was chosen because DT104 transformed with insertless pCR-Blunt 11-TOPO did not exhibit any significant fluorescence. Using BamHl and NotI sites in the multiple cloning sites of each vector, the ECFP gene was transferred into pCR-Blunt lI-TOPO. Specifically, both vectors were digested for 4 h in a single 20-ML reaction. DNA was precipitated by adding 0.1 volumes of 3 M sodium acetate (pH 5.5) and 2.5 volumes of 95% ethanol and then centrifuged at 15 000 rpm for 15 min at 4°C. Ligation of DNA was performed using T4 DNA ligase (New England Biolabs, Beverly, MA, USA) at 14°C for 4 h. Electroporation into S. tphimuriuni LB5000 then ensued using the procedure described above. Transformants were plated on low-salt Lennox L agar plates containing 25 ig/mL Zeocin as per the manufacturer's protocol. A single fluorescent colony was selected and amplified in 100 mL Lennox L broth containing 25 .tg/mL Zeocin. Plasmid DNA from S. i'yphimurium LB5000IECFP/pCR-Blunt 11-TOPO was prepared using the EndoFreelNi plasmid prep kit (Qiagen, Valencia, CA, USA). Plasmid DNA was then electroporated (as described above for S. typhiinurium LB5000) into electrocompetent versions of multiresistant DT104 or Salmonella dublin ( prepared as described above for S. tvphimuriuin LB 5000). Transformants were plated on low-salt Lennox L agar plates containing 25 1g/mL Zeocin. All colonies exhibited the fluorescence pattern observed previously in S. tvphimuriuin LB5000 expressing ECFP.
Phenotypic evaluations of DT104/ ECFP/pCR-Blunt 11-TOPO included performing tissue culture invasion assays and antibiotic resistance profiles. These studies revealed that the inclusion of the ECFP/pCR-Blunt 11-TOPO had no effect on growth curves, invasion, or Zeocin-independent antibiograms while fluorescence was maintained in these assays (data not shown). Fluorescence was maintained for up to 50 propagations (0.1% subculturing followed by overnight propagation, data not shown) under nonselective conditions. Exposure to 16 different antibiotics had no effect on expression of A 10-cm Lennox agar plate was plated with 2.5 x 108 DTIO4IECFP/pCR-Blunt 11-TOPO. Then approximately 10 of microcin-producing E. coli 2424 were spotted in the center of the plate. After an overnight incubation, a zone of inhibition was visualized under a standard UV light box (GelD0cT M system; Bio-Rad Laboratories).
Benchmarks

ECFP (not shown).
To evaluate the utility of the ECFP expression in 1)T104, we performed an overlay assay to determine the sensitivity/resistance of DT 104 to microcin 24, an E. co/i-derived antimicrobial peptide (3). Approximately 2.5 x 108 DTI04/ ECFP/pCR-Blunt 11-TOPO were plated on a 10-cni plastic petri dish containing Lennox L agar and 100 ig/mL ampicillin. Then, approximately 1()4 of uropathogenic E. co/i 2424 (i.e., a strain that expresses microcin 24 from a plasmid bearing an ampicillin resistance gene) (3) were spotted on the agar in the center of the plate. Cultures were grown overnight, after which a zone of inhibition was visualized under UV light (Figure 1 ).
This report details the exogenous expression of a GFP-like molecule in multiple antibiotic-resistant Salmonella. The utility of this expression system was demonstrated by the use of an antimicrobial resistance assay in which two potentially antagonistic bacteria were simultaneously grown together. We anticipate that this system could be used in other in vitro and ex vivo assays, especially where long-term bacterial propagation is necessary, and in other multiple antibiotic-resistant bacteria.
